Acadia Pharmaceuticals reported $0 in EPS Earnings Per Share for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Acadia Pharmaceuticals ACAD:US USD 0 0
ALKERMES ALKS:US USD 0.14 0.12
Alnylam Pharmaceuticals ALNY:US USD -1.68 1.01
Aptinyx Inc APTX:US USD -0.23 0.03
Biogen BIIB:US USD 4.05 0.72
Biomarin Pharmaceutical BMRN:US USD 0.36 0.4
Bristol Myers Squibb BMY:US USD 1.82 0.17
Cara Therapeutics CARA:US USD -0.56 0.13
Corcept Therapeutics CORT:US USD 0.14 0.16
Cytokinetics CYTK:US USD -1.45 0.07
Eisai 4523:JP JPY 30.14 17.7
Eli Lilly And LLY:US USD 2.09 0.11
Intercept Pharmaceuticals ICPT:US USD -0.5 8.3
Intra Cellular Therapies ITCI:US USD -0.45 0.12
Johnson & Johnson JNJ:US USD 2.35 0.2
Marinus Pharmaceuticals MRNS:US USD -0.76 0.18
Moderna Inc MRNA:US USD 3.61 1.08
Neurocrine Biosciences NBIX:US USD 0.88 0.19
Pfizer PFE:US USD 1.14 0.64
Prothena PRTA:US USD 0.12 1.09
Ptc Therapeutics PTCT:US USD -1.89 0.36
Sarepta Therapeutics SRPT:US USD -1.24 1.7
Seattle Genetics SGEN:US USD -0.8 0.23
Ultragenyx Pharmaceutical RARE:US USD -2.16 1.34
Vanda Pharmaceuticals VNDA:US USD 0.12 0.06
Vertex Pharmaceuticals VRTX:US USD 3.76 0.25
YTE INCY:US USD 0.62 0.02